The impact of the introduction of drug-eluting stents on the clinical practice of surgical and percutaneous treatment of coronary artery disease — Ron T. van Domburg (2005) | RDL Network
The impact of the introduction of drug-eluting stents on the clinical practice of surgical and percutaneous treatment of coronary artery disease
European Heart Journal 26(7): 675-681
Article 2005 English
Authors
RD
Ron T. van Domburg
PL
Pedro A. Lemos
JT
Johanna J.M. Takkenberg
Abstract
1 min read
Aims Sirolimus-eluting stents (SES) have recently been shown to reduce restenosis in selected patients. The impact of this new stent on the use of coronary bypass graft (CABG) surgery or percutaneous coronary intervention (PCI) in clinical practice is yet unknown. Therefore, we investigated the impact of SES on the clinical practice of CABG and PCI in a series of unselected consecutive patients.
Angela Hoye, Pedro A. Lemos, Chourmouzios A. Arampatzis, Francesco Saia, Kengo Tanabe, Muzaffer Değertekin, Sjoerd H. Hofma, Eugène McFadden, Georgios Sianos, Pieter C. Smits, Willem J. van der Giessen, Pim de Feyter, Ron T. van Domburg, Patrick W. Serruys
Cheol Whan Lee, Jung‐Min Ahn, Rafael Cavalcante, Yohei Sotomi, Yoshinobu Onuma, Pannipa Suwannasom, Erhan Tenekecioğlu, Sung‐Cheol Yun, Duk‐Woo Park, Soo‐Jin Kang, Seung‐Whan Lee, Young‐Hak Kim, Seong‐Wook Park, Patrick W. Serruys, Seung‐Jung Park
Stuart J. Head, Milan Milojevic, Joost Daemen, Jung‐Min Ahn, Eric Boersma, Evald Høj Christiansen, Michaël Domanski, Michael E. Farkouh, Marcus Flather, Valentı́n Fuster, Mark A. Hlatky, Niels Ramsing Holm, Whady Hueb, Masoor Kamalesh, Young‐Hak Kim, Timo H. Mäkikallio, Friedrich W. Mohr, Grigorios Papageorgiou, Seung‐Jung Park, Alfredo E. Rodríguez, Joseph F. Sabik, Rod Stables, Gregg W. Stone, Patrick W. Serruys,
Discussion(0)
No comments yet. Be the first to comment.